Public Health Groups Sue FDA Over Flavored E-Cigarette Policy

A group of public health organizations has filed a lawsuit against the Food and Drug Administration (FDA) in an attempt to halt a new policy allowing flavored e-cigarettes and nicotine pouches to enter the market without undergoing the usual scientific review process.

Background of the Lawsuit

The lawsuit calls for a judge to overturn a policy announced in May. This policy was finalized shortly after company executives advocating for the policy met with President Trump at his golf club in Florida. Notably, two days before this meeting, Reynolds American, a company with representatives present at the meeting, donated $5 million to a super PAC supporting the president, according to campaign finance records.

Implications of the New Policy

The new FDA policy states that the agency will not enforce its authority against companies making significant progress toward an agency approval decision. This change is expected to allow large tobacco companies to begin selling new flavored tobacco products and e-cigarettes soon.

Previously, the FDA only allowed the sale of vapes in menthol or plain tobacco flavors, which are considered less attractive to youth. However, unauthorized products with high nicotine levels and flavors like strawberry slushie have been flooding in from China, being sold illegally across the United States.

Public Health Groups’ Concerns

The lawsuit is led by the Campaign for Tobacco-Free Kids and includes the American Lung Association, American Heart Association, American Cancer Society Cancer Action Network, and the American Academy of Pediatrics.

These groups argue that the new FDA policy violates the Tobacco Control Act. This act, established during the Obama administration, requires each e-cigarette and tobacco pouch to undergo a comprehensive FDA review before receiving a “marketing granted order,” akin to approval. The review assesses whether a product is suitable for public health protection, often based on company studies showing its effectiveness in helping adults quit smoking while not attracting young users.